Philip Hall to Prognosis
This is a "connection" page, showing publications Philip Hall has written about Prognosis.
Connection Strength
0.030
-
Adjuvant therapy of node-negative breast cancer. Ann Pharmacother. 1995 Mar; 29(3):289-98.
Score: 0.021
-
A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 1):3555-61.
Score: 0.009